The nature of the final oxidative step in the aromatization sequence.

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Steroids

• Publication date

  1987-10-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0039-128X(87)90023-7PMID 3332932
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• ESTROGEN BIOSYNTHESIS: CONCERNING THE OBLIGATORY INTERMEDIACY OF 2β-HYDROXY-10β-FORMYL ANDROST-4-ENE-3,17-DIONE

  1985cited by this paper
• Estrogen biosynthesis: concerning the obligatory intermediacy of 2.beta.-hydroxy-10.beta.-formyl androst-4-ene-3,17-dione

  1984cited by this paper
• Immunological probe of estrogen biosynthesis. Evidence for the 2 beta-hydroxylative pathway in aromatization of androgens.

  1984cited by this paper
• Biochemical mechanism of aromatization.

  1982cited by this paper
• Mechanistic studies on C-19 demethylation in oestrogen biosynthesis.

  1982cited by this paper
• Mechanism of estrogen biosynthesis. Stereochemistry of C-1 hydrogen elimination in the aromatization of 2 beta-hydroxy-19-oxoandrostenedione.

  1981cited by this paper
• Localization of estrogen synthetase in the chorionic villus fraction after homogenization of human term placenta.

  1977cited by this paper
• Participation of a nonenzymatic transformation in the biosynthesis of estrogens from androgens.

  1977cited by this paper
• Kinetic properties of human placental aromatase. Application of an assay measuring 3H2O release from 1beta,2beta-3H-androgens.

  1976cited by this paper
• Conversion of an androgen epoxide into 17beta-estradiol by human placental microsomes.

  1975cited by this paper
• REASSIGNMENT OF THE ABSOLUTE CONFIGURATION OF 19-SUBSTITUTED 19-HYDROXYSTEROIDS AND STEREOMECHANISM OF ESTROGEN BIOSYNTHESIS

  1975cited by this paper
• Letter: Reassignment of the absolute configuration of 19-substituted 19-hydroxysteroids and stereomechanism of estrogen biosynthesis.

  1975cited by this paper
• Utilization of oxygen and reduced nicotinamide adenine dinucleotide phosphate by human placental microsomes during aromatization of androstenedione.

  1974cited by this paper
• Unusually facile aromatization of 2 beta-hydroxy-19-oxo-4-androstene-3, 17-dione to estrone. Implications in estrogen biosynthesis.

  1974cited by this paper
• Utilization of oxygen and reduced nicotinamide adenine dinucleotide phosphate by human placental microsomes during aromatization of androstenedione.

  1974cited by this paper
• Formation of steroids by the pregnant mare. IV. Metabolism of 14 C-mevalonic acid and 3 H-dehydroisoandrosterone injected into the fetal circulation.

  1973cited by this paper
• Stereochemistry of estrogen biosynthesis.

  1969cited by this paper
• Studies on the mechanism of estrogen biosynthesis. VI. The stereochemistry of hydrogen elimination at C-2 during aromatization.

  1969cited by this paper
• Studies on the mechanism of estrogen biosynthesis. 3. The stereochemistry of aromatization of C19 and C18 steroids.

  1968cited by this paper
• Biological aromatization of steroids.

  1959cited by this paper
• THE STEREOCHEMISTRY OF 7α-HYDROXYLATION IN THE BIOSYNTHESIS OF CHOLIC ACID FROM CHOLESTEROL

  1958cited by this paper
• Conversion of 19-hydroxy-delta 4-androstene-3,17-dione to estrone by endocrine tissue.

  1955cited by this paper
• Conversion of 19-hydroxy-Δ4-androstene-3,17-dione to estrone by endocrine tissue

  1955cited by this paper

• Endocrine Therapy for Hormone Receptor‐Positive Breast Cancer

  2019cites this paper
• Substituted androstanes as aromatase inhibitors

  2010cites this paper
• Aromtase Inhibitors in Breast Cancer

  2002cites this paper
• Wirkungsweise und Stellenwert der neuen Aromatasehemmer in der Therapie des Mammakarzinoms

  1999cites this paper
• Use of aromatase inhibitors in breast carcinoma.

  1999cites this paper
• Endocrinology of Breast Cancer

  1999cites this paper
• Aromatase Inhibitors in Breast Carcinoma

  1999cites this paper
• Aromatization of a bicyclic steroid analog, 3-oxodecalin-4-ene-10-carboxaldehyde, by liver microsomal cytochrome P450 2B4.

  1994cites this paper
• A-ring bridged steroids as potent inhibitors of aromatase.

  1993cites this paper
• Biological characterization of A-ring steroids.

  1993cites this paper
• Studies on estrogen biosynthesis using radioactive and stable isotopes.

  1990cites this paper
• Conversion of 19-oxo[2 beta-2H]androgens into oestrogens by human placental aromatase. An unexpected stereochemical outcome.

  1990cites this paper
• The constitutive 7-ethoxycoumarin 0-deethylase of human placental microsomes: relationship to the intermediary steps in steroid aromatization.

  1990cites this paper
• Aromatase inhibition by R 76 713: a kinetic analysis in rat ovarian homogenates.

  1990cites this paper
• Clinical use of aromatase inhibitors: current data and future perspectives.

  1990cites this paper